Dr Lalchandani Labs Quarterly Results for Trading Insights
In 2026, Dr Lalchandani Labs (DLCL) reported revenue ₹0 Cr and net profit ₹0 Cr. Also explore DLCL price movement history to track price trends across different timeframes.
DLCL Quarterly Results — Revenue, Profit & EPS Highlights
Dr Lalchandani Labs latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit DLCL share price screener.
- Revenue of ₹5 Cr in March 2025 (+0.0% vs March 2025, +0.0% vs March 2024)
- EBITDA of ₹1 Cr in March 2025 (+0.0% vs March 2025)
- Operating Margin of 21.0% in March 2025 (+0.0pp vs March 2025)
- Earnings Per Share of ₹0.96 in March 2025 (+0.0% vs March 2025)
Dr Lalchandani Labs Quarterly Results — Revenue, EBITDA, Net Profit & EPS
DLCL quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | 2026 | March 2025 | March 2024 | March 2023 | March 2022 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 0 | 5 | 5 | 5 | 11 | - | - |
| Net Profit (₹ Cr) | 0 | 0 | 1 | -2 | 1 | - | - |
| EBITDA (₹ Cr) | 0 | 1 | 0 | 0 | 2 | - | - |
| EPS (₹) | 0.00 | 0.96 | 1.43 | -3.61 | 2.15 | - | - |
| Operating Margin (%) | 0.0% | 21.0% | 4.0% | 2.0% | 21.0% | - | - |
DLCL Share Price Trend — 1-Year Movement Across Quarterly Results
Dr Lalchandani Labs 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Compare with DLCL fair price to assess whether the stock is under or overvalued.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
DLCL vs Healthcare Services Peers — Quarterly Revenue, Profit & Market Cap
Dr Lalchandani Labs latest quarter revenue and net profit vs Healthcare Services competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Apollo Hospitals
Mar 2026 |
₹120,239.92 Cr | 8362.5 | 6,660 | 551 | +4.6% | +17.6% | 8.3% | 227.1 |
|
Max Healthcare Inst…
Sept 2025 |
₹102,188.91 Cr | 1023.3 | 2,168 | 491 | +10.8% | - | 22.6% | 202.6 |
|
Fortis Healthcare
Sept 2025 |
₹72,751.54 Cr | 960.4 | 2,381 | 329 | +17.2% | - | 13.8% | 225.4 |
|
Aster DM Healthcare
Mar 2026 |
₹39,048.19 Cr | 756.6 | 1,219 | 154 | -0.6% | +18.1% | 12.6% | 278.2 |
|
Narayana Hrudayalaya
Sept 2025 |
₹37,624.87 Cr | 1855.6 | 1,668 | 259 | +11.0% | - | 15.5% | 145.9 |
All amounts in ₹ Crores